Company news

Verici Dx Plc (LSE:VRCI) news

Every Verici Dx Plc press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Verici Dx Plc stock analysis →

Press releases & updates

Certified Service Provider agreement with Olink®

August 11, 2026

Investor presentation

July 6, 2026

Final results for the year ended 31 December 2025

June 29, 2026

New York State clinical lab certification received

June 24, 2026

WRAP Retail Offer for up to £200,000

June 8, 2026

Result of Placing & raising gross proceeds c£2.5m

June 5, 2026

AMA grants additional CPT® Code for ProtegaTM

June 2, 2026

Clinical study validating PTRA test published

May 19, 2026

Positive Q1 Trading Update

April 16, 2026

Board Change

March 31, 2026

FY25 Trading Update

February 5, 2026

Agreement with BCBS of Illinois for Tutivia™

February 5, 2026

Completion of CAP accreditation audit

November 12, 2025

Provider Participation Agreement with Prime Health

November 6, 2025

Completion of ISO 27001 surveillance audit

November 3, 2025

Options revision & Grant of new share options

October 30, 2025

Board Changes

October 6, 2025

Update on Tutivia™ test adoption

October 6, 2025

Holding(s) in Company

October 1, 2025

Half-year Report

September 30, 2025

Tutivia™ abstracts for World Transplant Congress

July 31, 2025

Result of Annual General Meeting

July 30, 2025

Result of WRAP Retail Offer

July 29, 2025

WRAP Retail Offer for up to £500,000

July 22, 2025

Result of Placing & Subscription

July 21, 2025

Proposed Fundraising

July 21, 2025

Final Results

June 30, 2025

Update on funding to accelerate commercial growth

June 11, 2025

Result of General Meeting

May 27, 2025

Publication of Circular

May 9, 2025

Verici Receives Medicare Coverage for Tutivia

April 10, 2025

Significant Test Growth with Medicare Pending

April 7, 2025

Update on Local Coverage Determination and Trading

October 11, 2024

Launch of PTRA Assay using Verici Dx's technology

July 31, 2024

Notice of Results and Business Update

July 11, 2024

Significant milestone re Thermo Fisher agreement

July 1, 2024

Result of AGM

June 25, 2024

Transfer of urine samples to Thermo Fisher

June 18, 2024

Notice of AGM and posting of Annual Report

May 31, 2024

Launch of patient-focused educational tool

May 31, 2024

2023 Annual Results

May 30, 2024

New data to be presented at ATC

May 24, 2024

Result of Retail Offer

February 14, 2024

Verici Dx announces new research initiative

January 31, 2024

Launch of Retail Offer

January 25, 2024

Result of Placing

January 24, 2024

Close of Accelerated Bookbuild

January 24, 2024

CAP accreditation

January 8, 2024

Medicare National Payment Rate Confirmation

January 8, 2024

Tutivia™ validation study published in Journal

December 11, 2023

Older →